A Study of LY4515100 in Healthy Participants
Phase 1
40
about 6 months
18–65
1 site in TX
What this study is about
This trial is testing the safety and how well LY4515100 is tolerated when given to healthy people. Blood tests will be done to see how the body processes the drug and its effects on the body. The study will last up to 30 days and include six overnight stays.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take LY4515100 via MAD
- 2.Take LY4515100 via SAD
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Number of participants with one or more serious adverse event(s) (SAEs) of LY4515100
Secondary: PK: Maximum Observed Drug Concentration (Cmax) of LY4515100, PK: Time of maximum observed drug concentration (tmax) of LY4515100, Pharmacokinetics (PK): Area Under the Concentration versus Time Curve (AUC) of LY4515100